SK1062001A3 - Isoquinolines as urokinase inhibitors - Google Patents

Isoquinolines as urokinase inhibitors Download PDF

Info

Publication number
SK1062001A3
SK1062001A3 SK106-2001A SK1062001A SK1062001A3 SK 1062001 A3 SK1062001 A3 SK 1062001A3 SK 1062001 A SK1062001 A SK 1062001A SK 1062001 A3 SK1062001 A3 SK 1062001A3
Authority
SK
Slovakia
Prior art keywords
chloro
isoquinolyl
mmol
guanidine
sulfonyl
Prior art date
Application number
SK106-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Christopher Gordon Barber
Roger Peter Dickinson
Paul Vincent Fish
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB1999/001289 external-priority patent/WO2000005214A2/fr
Publication of SK1062001A3 publication Critical patent/SK1062001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SK106-2001A 1998-07-24 1999-07-15 Isoquinolines as urokinase inhibitors SK1062001A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9816228.2A GB9816228D0 (en) 1998-07-24 1998-07-24 Isoquinolines
GBGB9908829.6A GB9908829D0 (en) 1998-07-24 1999-04-16 Isoquinolines
PCT/IB1999/001289 WO2000005214A2 (fr) 1998-07-24 1999-07-15 Isoquinoleines utilisees en tant qu'inhibiteurs de l'urokinase

Publications (1)

Publication Number Publication Date
SK1062001A3 true SK1062001A3 (en) 2001-11-06

Family

ID=10836172

Family Applications (1)

Application Number Title Priority Date Filing Date
SK106-2001A SK1062001A3 (en) 1998-07-24 1999-07-15 Isoquinolines as urokinase inhibitors

Country Status (39)

Country Link
EP (1) EP1077945B1 (fr)
JP (1) JP2002521367A (fr)
KR (1) KR20010083137A (fr)
CN (1) CN1318059A (fr)
AR (1) AR018960A1 (fr)
AT (1) ATE230730T1 (fr)
AU (1) AU745545B2 (fr)
BG (1) BG105252A (fr)
BR (1) BR9912374A (fr)
CA (1) CA2337247A1 (fr)
CO (1) CO5080787A1 (fr)
DE (1) DE69904814T2 (fr)
DK (1) DK1077945T3 (fr)
DZ (1) DZ2852A1 (fr)
EA (1) EA200100073A1 (fr)
EE (1) EE200100049A (fr)
ES (1) ES2189434T3 (fr)
GB (2) GB9816228D0 (fr)
GT (1) GT199900116A (fr)
HK (1) HK1040996A1 (fr)
HN (1) HN1999000116A (fr)
HR (1) HRP20010059A2 (fr)
HU (1) HUP0103665A3 (fr)
ID (1) ID26993A (fr)
IS (1) IS5789A (fr)
MA (1) MA26664A1 (fr)
NO (1) NO20010400L (fr)
OA (1) OA11578A (fr)
PA (1) PA8478901A1 (fr)
PE (1) PE20000937A1 (fr)
PL (1) PL346022A1 (fr)
PT (1) PT1077945E (fr)
SI (1) SI1077945T1 (fr)
SK (1) SK1062001A3 (fr)
TN (1) TNSN99149A1 (fr)
TR (1) TR200100222T2 (fr)
TW (1) TW530049B (fr)
UY (1) UY25663A1 (fr)
ZA (1) ZA200100230B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003219039A1 (en) * 2002-03-11 2003-09-22 Curacyte Ag Urokinase inhibitors, production and use thereof
JP4664924B2 (ja) 2003-12-02 2011-04-06 ウーツェーベー ファルマ ゲーエムベーハー 中枢神経因性疼痛の治療のためのペプチド化合物の新規使用
EP1604655A1 (fr) 2004-06-09 2005-12-14 Schwarz Pharma Ag Utilisation nouvelle de peptides pour le traitement de neuralgies trigeminales
EP1604656A1 (fr) 2004-06-09 2005-12-14 Schwarz Pharma Ag Utilisation nouvelle de peptides pour le traitement de la sclérose amytrophique latérale (ALS)
WO2007144195A2 (fr) 2006-06-15 2007-12-21 Schwarz Pharma Ag Composition pharmaceutique ayant un effet anticonvulsivant synergique

Also Published As

Publication number Publication date
AU4528999A (en) 2000-02-14
PL346022A1 (en) 2002-01-14
OA11578A (en) 2004-07-20
ATE230730T1 (de) 2003-01-15
BR9912374A (pt) 2001-04-17
HK1040996A1 (zh) 2002-06-28
CN1318059A (zh) 2001-10-17
TR200100222T2 (tr) 2001-12-21
HUP0103665A2 (hu) 2002-02-28
JP2002521367A (ja) 2002-07-16
SI1077945T1 (en) 2003-04-30
NO20010400D0 (no) 2001-01-23
GT199900116A (es) 2001-01-13
EP1077945A1 (fr) 2001-02-28
HRP20010059A2 (en) 2002-02-28
EE200100049A (et) 2002-06-17
EP1077945B1 (fr) 2003-01-08
PT1077945E (pt) 2003-03-31
CO5080787A1 (es) 2001-09-25
BG105252A (en) 2001-12-29
ID26993A (id) 2001-02-22
EA200100073A1 (ru) 2001-10-22
UY25663A1 (es) 2000-03-31
IS5789A (is) 2000-12-22
GB9908829D0 (en) 1999-06-16
ES2189434T3 (es) 2003-07-01
AR018960A1 (es) 2001-12-12
HN1999000116A (es) 2000-11-11
PE20000937A1 (es) 2000-09-18
MA26664A1 (fr) 2004-12-20
HUP0103665A3 (en) 2002-06-28
AU745545B2 (en) 2002-03-21
TW530049B (en) 2003-05-01
GB9816228D0 (en) 1998-09-23
KR20010083137A (ko) 2001-08-31
DE69904814T2 (de) 2003-04-30
ZA200100230B (en) 2002-03-01
DZ2852A1 (fr) 2003-12-01
NO20010400L (no) 2001-03-26
DE69904814D1 (de) 2003-02-13
DK1077945T3 (da) 2003-04-22
CA2337247A1 (fr) 2000-02-03
TNSN99149A1 (fr) 2005-11-10
PA8478901A1 (es) 2000-09-29

Similar Documents

Publication Publication Date Title
AU722384B2 (en) Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
US5648364A (en) Retroviral protease inhibitors
JPH0660144B2 (ja) シクロアルキル置換されたグルタルアミド抗高血圧剤
US6093731A (en) Isoquinolines
EP0927035A1 (fr) Inhibiteurs de thrombine
CA2282399A1 (fr) Composes d'acide hydroxamique sulfonamide thioaryle
RU2327688C2 (ru) Основные непептидные антагонисты брадикинина и их фармацевтические композиции
CA2305047A1 (fr) Inhibiteurs de la 2-pyridinylguanidine-urokinase
JP3600794B2 (ja) ウロキナーゼ阻害薬としてのイソキノリン類
JP2000503010A (ja) アミジノプロテアーゼ阻害剤
AU2277699A (en) Matrix metalloprotease inhibitors
SK1062001A3 (en) Isoquinolines as urokinase inhibitors
MXPA00004241A (es) Nuevos compuestos de 2,3-metano-amino acido, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
KR100668194B1 (ko) 아미노산 유도체, 이의 제조 방법 및 이를 포함하는 약제조성물
CZ2001289A3 (cs) Isochinoliny jako inhibitory urokinasy
MXPA01000888A (en) Isoquinolines as urokinase inhibitors
MXPA99011261A (en) Phenylalkyl derivatives with thrombin-inhibiting effect
MXPA97009386A (en) Derivatives of the arilsulfonilaminobenceno and the use of them as factor inhibitors
MXPA00003589A (en) 2-pyridinylguanidine urokinase inhibitors
PL173030B1 (pl) Nowe sulfonamidokarboksamidy i sposób ich wytwarzania